MFIM
ANIP icon

Mesirow Financial Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Mesirow Financial Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,996
Closed -$206K – 539
2025
Q1 		$206K Buy
+2,996
New +$179K ﹤0.01% 537
2024
Q1 		– Sell
-3,862
Closed -$218K – 531
2023
Q4 		$218K Hold
3,862
– – 0.01% 506
2023
Q3 		$224K Sell
3,862
-3,030
-44% -$175K 0.98% 67
2023
Q2 		$371K Hold
6,892
– – 1.57% 15
2023
Q1 		$274K Hold
6,892
– – 1.13% 45
2022
Q4 		$277K Hold
6,892
– – 1.16% 39
2022
Q3 		$222K Hold
6,892
– – 1.06% 52
2022
Q2 		$204K Buy
+6,892
New +$199K 0.99% 63
2022
Q1 		– Sell
-12,277
Closed -$566K – 82
2021
Q4 		$566K Hold
12,277
– – 1.63% 18
2021
Q3 		$403K Buy
12,277
+3,303
+37% +$103K 1.19% 51
2021
Q2 		$315K Buy
8,974
+24
+0.3% +$816 0.8% 76
2021
Q1 		$323K Sell
8,950
-380
-4% -$11.9K 0.88% 68
2020
Q4 		$271K Sell
9,330
-103
-1% -$2.95K 0.86% 68
2020
Q3 		$266K Buy
9,433
+1,252
+15% +$37.3K 1.14% 62
2020
Q2 		$265K Buy
8,181
+1,639
+25% +$58.8K 1.25% 49
2020
Q1 		$267K Buy
6,542
+819
+14% +$43.6K 1.68% 19
2019
Q4 		$353K Sell
5,723
-1,926
-25% -$128K 1.49% 38
2019
Q3 		$557K Sell
7,649
-490
-6% -$36.7K 2.34% 5
2019
Q2 		$673K Sell
8,139
-2,176
-21% -$155K 2.46% 10
2019
Q1 		$728K Buy
10,315
+3,288
+47% +$193K 2.89% 1
2018
Q4 		$316K Hold
7,027
– – 2.04% 20
2018
Q3 		$397K Sell
7,027
-2,228
-24% -$136K 2.05% 17
2018
Q2 		$618K Buy
9,255
+2,991
+48% +$187K 2.75% 4
2018
Q1 		$365K Buy
6,264
+2,768
+79% +$176K 1.54% 32
2017
Q4 		$225K Sell
3,496
-7,600
-68% -$473K 1.02% 52
2017
Q3 		$582K Buy
11,096
+280
+3% +$13.4K 2.74% 5
2017
Q2 		$506K Buy
+10,816
New +$522K 2.39% 12

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Mesirow Financial Investment Management's ANIP Position: Q2 2025 in Review

Mesirow Financial Investment Management sold out of ANI Pharmaceuticals (ANIP) in Q2 2025, closing a stake of 2,996 shares — an estimated $206K sold.

Mesirow Financial Investment Management first reported a position in ANIP in Q2 2017 and held it in 27 quarters. The position peaked at $728K in Q1 2019. 232 funds tracked by Wall St. Rank hold ANIP as of Q2 2025.

  • Mesirow Financial Investment Management reported no remaining ANI Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 2,996 ANI Pharmaceuticals shares in Q2 2025, an estimated $206K.
  • Mesirow Financial Investment Management first reported a position in ANI Pharmaceuticals in Q2 2017 and held it in 27 quarters.
  • Mesirow Financial Investment Management's ANI Pharmaceuticals position peaked at $728K in Q1 2019.
  • 232 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2025.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2025, filed 4 Aug 2025.